Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Oliver Schlager: New ESC and ESVM Clinical Consensus on Lipid-Lowering Therapy in VTE
Sep 12, 2026, 04:04

Oliver Schlager: New ESC and ESVM Clinical Consensus on Lipid-Lowering Therapy in VTE

Oliver Schlager, Head of the Department of Internal Medicine 1 – Angiology at Göttlicher Heiland Hospital Vienna, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:

“Very pleased to share our new Clinical Consensus Document on Lipidlowering Therapy in Venous Thromboembolism of the European Society of Cardiology (ESC) Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Society of Vascular Medicine (ESVM).”

Title: Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, and the European Society of Vascular Medicine (ESVM)

Authors: Christine Espinola-Klein, Christian Heiss, Marianne Brodmann, Thomas Gary, Lucia Mazzolai, Alessandra Bura-Riviere, Birgit Linnemann, Victor Aboyans, José F Rodriguez Palomares, Frederikus A Klok, Heinz Drexel, Jill Belch, Mislav Vrsalovic, Oliver Schlager

Oliver Schlager

Stay updated on all scientific advances with Hemostasis Today.